# Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape)

Study · id `cardio:ct-nct01361425` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01361425](<https://clinicaltrials.gov/study/NCT01361425>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01361425

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT01361425. Randomized; triple masking; primary purpose treatment. Start 2011-05 (registry gives no type); primary completion 2012-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT01361425, source copy `cardio:ctgov-nct01361425-2011-05-30`, retrieved 2026-10-26)
- Start date: 2011-05 (registry gives no type) (ClinicalTrials.gov record NCT01361425, source copy `cardio:ctgov-nct01361425-2011-05-30`, retrieved 2026-10-26)
- Primary completion: 2012-05 (anticipated) (ClinicalTrials.gov record NCT01361425, source copy `cardio:ctgov-nct01361425-2011-05-30`, retrieved 2026-10-26)
- Completion: 2013-02 (anticipated) (ClinicalTrials.gov record NCT01361425, source copy `cardio:ctgov-nct01361425-2011-05-30`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT01361425, source copy `cardio:ctgov-nct01361425-2011-05-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01361425-2011-05-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape)
- Acronym: METILDOPAPE
- Condition: Preeclampsia
- Intervention (Drug): methildopa
- Intervention (Drug): placebo
- Lead sponsor: Professor Fernando Figueira Integral Medicine Institute
- Lead sponsor class: OTHER
- Collaborator: Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as a collaborator: Conselho Nacional de Desenvolvimento Científico e Tecnológico (`cardio:org-conselho-nacional-de-desenvolvimento-cientifico-e-e18697`)

## Provenance

Content hash: 4abac111977a8d6216c9c7bf95c4511e675b7ff75ca77d80a34b04a92fcb502c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
